In a report released today, Ricky Goldwasser from Morgan Stanley maintained a Hold rating on Athenahealth (ATHN), with a price target of $135. The company’s shares closed on Friday at $133.10.
According to TipRanks.com, Goldwasser is a 3-star analyst with an average return of 3.0% and a 56.2% success rate. Goldwasser covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Walgreens Boots Alliance, and Quest Diagnostics Inc.
Athenahealth has an analyst consensus of Hold, with a price target consensus of $136.08, representing a 2.2% upside. In a report issued on November 27, Wells Fargo also downgraded the stock to Hold with a $135 price target.
.
See today’s analyst top recommended stocks >>
The company has a one-year high of $163.94 and a one-year low of $116.77. Currently, Athenahealth has an average volume of 1M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
athenahealth, Inc. engages in the provision of cloud-based business services and mobile applications for medical groups and health systems. It offers network-based medical record, revenue cycle, patient engagement, care coordination, population health services, and other point-of-care mobile applications.
